Acrux
ACR.AXAcrux Limited Price (ACR.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
289,499,999
(1.0608)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.022-0.099
- Market Cap 9.37M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus
- IPO Date: September, 29, 2004
- Country: AU
- Currency: AUD
- Headquaters: West Melbourne, VIC
- Employees: 43
- Revenue from each product or segment:
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|
- Revenue by Region
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|